Announcement on Risk Warning of Diluted Immediate Returns and Measures to Compensate for Diluted Returns and Related Party Commitments (Revised Draft)
Company Code: 002688 Securities Abbreviation: Jinhe Bio Announcement Number: 2026-063
Jinhe Bio-Tech Co., Ltd.
Announcement on Risk Warning of Diluted Immediate Returns and Measures to Compensate for Diluted Returns and Related Party Commitments for the Company's Simplified Procedure Issuance of Shares to Specific Objects in 2025 (Revised Draft)
The Board of Directors and the entire management team guarantee the authenticity, accuracy, and completeness of the information disclosed in this announcement, and are jointly and severally liable for any false representations, misleading statements, or material omissions.
Important Notice
-
This announcement is made by Jinhe Bio-Tech Co., Ltd. (hereinafter referred to as the "Company") regarding the risk warning of diluted immediate returns from the simplified procedure issuance of shares to specific objects and the measures to compensate for such dilution. The analysis and calculation of the financial data in this announcement are based on the Company's forecast. Investors should not make investment decisions based solely on this announcement, and the Company shall not be liable for any losses incurred by investors.
-
The Company's commitment to compensating for diluted immediate returns and related matters shall not be construed as a guarantee against future risks. Investors are advised to pay attention to investment risks.
In order to further strengthen the protection of small and medium investors' legitimate rights and interests in the capital market, as required by the "Opinions of the General Office of the State Council on Further Strengthening the Protection of Investors' Legitimate Rights and Interests in the Capital Market" (Guofa [2013] No. 110) and the "Opinions of the China Securities Regulatory Commission on Further Improving the Protection of Investors' Legitimate Rights and Interests in the Capital Market" (Guofa [2014] No. 17) and the "Notice of the China Securities Regulatory Commission on Strengthening the Supervision of Listed Companies" (Guofa [2015] No. 31) and other relevant regulations, the Company has formulated the following measures to compensate for the diluted immediate returns from the simplified procedure issuance of shares to specific objects, based on the actual situation:
- Analysis of the impact of the current issuance on the Company's main financial indicators.
(I) Assumptions
The Company analyzes the impact of the issuance of shares to specific objects under a simplified procedure on the Company's main financial indicators based on the following assumptions. These assumptions do not constitute any forecast or commitment. Investors who make investment decisions based on these assumptions and incur losses shall not be liable for compensation. The issuance plan and actual issuance completion time for this simplified procedure issuance of shares to specific objects shall be subject to the actual situation after the China Securities Regulatory Commission's registration and approval. The specific assumptions are as follows:
-
It is assumed that there are no significant adverse changes in the macroeconomic environment, industrial policies, industry development, market conditions, and the Company's operating conditions.
-
It is assumed that the Company will complete this issuance in August 2026. This completion time is for estimation purposes only for this calculation. The final completion time shall be subject to the actual issuance completion time after the China Securities Regulatory Commission's registration and approval.
-
When forecasting the Company's total share capital after the issuance, the calculation is based on the total share capital of 769,504,398 shares before the issuance. Only the impact of the issuance of A-shares to specific objects is considered. The impact of the vesting and cancellation of restricted shares, the exercise of stock options, and other factors (such as capital reserve increase, stock dividends, conversion of convertible bonds, etc.) that cause changes in share capital are not considered. The impact of share repurchases and treasury shares on earnings per share is also not considered.